Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol vs conventional anesthesia in cardiac surgery with cardiopulmonary bypass
ChiCTR2200061714Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Guizhou Medical University
- Start
- Nov 2022
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciprofol in cardiac disease, coronary arteriosclerosis and Cardiac valve disease (VHD) (2 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoints: Rate of intraoperative hemodynamic fluctuations and Incidence of acute kidney injury. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
ciprofol
03
Conditions
cardiac diseasecoronary arteriosclerosisCardiac valve disease (VHD)
Beyond the preview
Go deeper on ChiCTR2200061714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061714.